Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Revenue projections:

Revenue projections for MDT
Revenue projections for MDT

MDT's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 2.535000
forwardPE 13.768627
debtToEquity 57.060000
earningsGrowth -0.118000
revenueGrowth 0.087000
grossMargins 0.651590
operatingMargins 0.200070
trailingEps 3.580000
forwardEps 6.060880

MDT's current ratio, being 2.535, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, MDT is well-equipped to meet its immediate financial obligations without any difficulties.
MDT's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
MDT's low growth in earnings and revenue indicates that profits could shrink. This signals potential financial difficulties for the company, suggesting that its profitability might be under pressure.
With positive gross and operating margins, MDT demonstrates strong profitability. This reflects the company's ability to manage costs and maintain healthy profits, showcasing effective operational efficiency and financial stability.
MDT's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that MDT is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for MDT
Price projections for MDT

The price of MDT currently does not indicate any clear risks or opportunities when compared to projections. This balanced stance suggests that investors may prefer to hold off on major decisions until new information arises.

Insider Transactions:

Insider Transactions for MDT
Insider Transactions for MDT


There were 3 MDT stock sales, with market price at 96.72333272298177.1 MDT stock purchases took place, with market price of 92.04000091552734.MDT has seen more buys than sells at its current price levels, which may suggest optimism among investors. This buying trend could indicate that the market expects a favorable performance for the stock in the near future.

Recommendation changes over time:

Recommendations trend for MDT
Recommendations trend for MDT


The recent buy bias from analysts suggests MDT is seen as a strong investment, encouraging more investors to consider it. With this favorable sentiment, MDT appears to be a reliable option for parking money, offering stability and long-term growth potential in the stock market.